论文部分内容阅读
支气管哮喘是呼吸系统的常见疾病之一,是由多种细胞和细胞组分参与的气道慢性炎症性疾病,其发病机制不完全清楚,随着哮喘病理生理和不同炎症表型的知识不断增加,多种因素参与其发病过程的理论也在逐渐被实践证实。其中尾加压素Ⅱ就可能是参与支气管哮喘的发病过程并发挥重要生物学效应的因素之一。本文就尾加压素Ⅱ在支气管哮喘病理生理中的作用予以简要综述。
Bronchial asthma is one of the most common respiratory diseases. It is a chronic airway inflammatory disease involving many kinds of cells and cellular components. The pathogenesis of bronchial asthma is not completely understood. With the increasing knowledge of the pathophysiology of asthma and different inflammatory phenotypes , Many factors involved in the pathogenesis of the theory is gradually being confirmed by practice. Urotensin II may be involved in the pathogenesis of bronchial asthma and play an important biological effects of one of the factors. This article summarizes the role of urotensin II in the pathophysiology of bronchial asthma.